JIANMIN GROUP(SH:600976) Zheng Xing Xing Ye Ri Bao·2025-09-08 08:53Market Overview - The Chinese traditional medicine sector rose by 1.24% on September 8, with Jianmin Group leading the gains [1] - The Shanghai Composite Index closed at 3826.84, up 0.38%, while the Shenzhen Component Index closed at 12666.84, up 0.61% [1] Top Performers - Jianmin Group (600976) closed at 43.36, up 4.23% with a trading volume of 66,000 shares and a turnover of 280 million yuan [1] - Qizheng Pharmaceutical (002287) closed at 28.64, up 4.15% with a trading volume of 173,000 shares [1] - Zhaoli Pharmaceutical (300181) closed at 18.86, up 3.97% with a trading volume of 222,100 shares [1] - Yiling Pharmaceutical (002603) closed at 17.03, up 3.90% with a trading volume of 447,300 shares [1] Underperformers - ST Xiangxue (300147) closed at 11.05, down 1.69% with a trading volume of 211,600 shares [2] - Zhendong Pharmaceutical (300158) closed at 7.96, down 0.50% with a trading volume of 384,600 shares [2] - Taiji Group (600129) closed at 22.29, down 0.45% with a trading volume of 180,300 shares [2] Capital Flow - The traditional medicine sector experienced a net outflow of 40.80 million yuan from institutional investors and 45.85 million yuan from speculative funds, while retail investors saw a net inflow of 86.65 million yuan [2] - Zhaoli Pharmaceutical (300181) had a net inflow of 62.71 million yuan from institutional investors, while retail investors had a net outflow of 54.18 million yuan [3] - Jianmin Group (600329) saw a net inflow of 28.68 million yuan from institutional investors, with retail investors experiencing a net outflow of 22.12 million yuan [3]